These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4572004)

  • 1. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial of a new anti-anginal drug: 2-benzofuryl-p-chlorophenyl carbinol (clobenfurol)].
    Abate G; Cuccurullo F; Curti A
    Minerva Cardioangiol; 1973 Feb; 21(2):145-53. PubMed ID: 4572419
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recent findings on the therapeutic effects of 2-benzofuryl-p-chlorophenylcarbinol in coronary disease].
    Zoli I; Battistini G; Mambelli M; Pretolani E
    Clin Ter; 1977 Aug; 82(4):351-87. PubMed ID: 334452
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical testing of 2-benzofuryl-p-chlorophenylcarbinol].
    Guarino V; Federico P; Telesco R; Varriale A
    Minerva Cardioangiol; 1974 May; 22(5):323-31. PubMed ID: 4619186
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of Peritrate in acute coronary insufficiency].
    Tricot R; Valère P; Castillo A
    Therapeutique; 1971 Nov; 47(9):777-8. PubMed ID: 4947933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 9. [New therapeutic possibilities in the field of coronary disease].
    Pretolani E; Coccheri S; Zoli I; Baroncini S; Donato S; De Rosa V
    Clin Ter; 1975 Feb; 72(3):225-53. PubMed ID: 1132215
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of cloridarol in coronary insufficiency].
    Mossuti E; Nigro P; Diene G; Petralito A
    Minerva Med; 1976 Apr; 67(21):1394-7. PubMed ID: 934497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 17. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical testing of a new combination product of a beta blocking agent and a nitroderivative].
    Melli A; Malagù I; Golinelli G; Soffritti A
    Minerva Med; 1970 Sep; 61(78):4271-8. PubMed ID: 4397054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.